Haemodialysis unit
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
16-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Nipro Australia Pty Ltd
Class:
Class IIb
Manufactured by:
Nipro Corporation 3-9-3 Honjo-nishi, Kita-Ku, Osaka, 531-8510 Japan
Therapeutic area:
34995 - Haemodialysis unit
Therapeutic indications:
Intended for use to perform Haemodialysis treatments. During Haemodialysis treatments extracorporeal Blood is passed through a haemodialysis unit that allows the transfer of substances by diffusion and convection for the purpose of decreasing biochemical abnormalities as well as fluid, electrolyte and acid - base imbalances.
Authorization status:
A
Authorization date:
2008-09-01
